LICITRA, LISA FRANCESCA LINDA

LICITRA, LISA FRANCESCA LINDA  

Dipartimento di Oncologia ed Emato-Oncologia  

Mostra records
Risultati 1 - 20 di 351 (tempo di esecuzione: 0.0 secondi).
Titolo Data di pubblicazione Autori Tipo File Abstract
Quality of life in head and neck cancer survivors: the Big Data for Quality of Life study 2024 Cavalieri SVener CLicitra L + Article (author) -
HeNeCOn: An ontology for integrative research in Head and Neck cancer 2024 Licitra LCavalieri S + Article (author) -
Association of a gene-expression subtype to outcome and treatment response in patients with recurrent/ metastatic head and neck squamous cell carcinoma treated with nivolumab 2024 Cavalieri S.Licitra L.Vingiani A. + Article (author) -
Tumor molecular landscape of Epstein-Barr virus (EBV) related nasopharyngeal carcinoma in EBV-endemic and non-endemic areas: Implications for improving treatment modalities 2024 Cavalieri S.Licitra L. + Article (author) -
HER2 status in recurrent/metastatic androgen receptor overexpressing salivary gland carcinoma patients 2023 Cavalieri S.Ottini A.Resteghini C.Licitra L. + Article (author) -
A clinicogenomic model including GARD predicts outcome for radiation treated patients with HPV+ oropharyngeal squamous cell carcinoma 2023 Cavalieri SLicitra L + Article (author) -
A multicenter randomized trial for quality of life evaluation by non-invasive intelligent tools during post-curative treatment follow-up for head and neck cancer: Clinical study protocol 2023 Cavalieri, StefanoMarton, GiuliaPravettoni, GabriellaLicitra, Lisa + Article (author) -
Multidisciplinary management of pregnancy-associated and early post-partum head and neck cancer patients 2023 Cavalieri S.Vingiani A.Deganello A.Licitra L. + Article (author) -
Dietary intervention for tertiary prevention in head and neck squamous cell carcinoma survivors: clinical and translational results of a randomized phase II trial 2023 Cavalieri S.Licitra L. + Article (author) -
Prognostic radiomic signature for head and neck cancer: Development and validation on a multi-centric MRI dataset 2023 Corino V.Cavalieri S.Licitra L. + Article (author) -
The observational clinical registry (cohort design) of the European Reference Network on Rare Adult Solid Cancers: The protocol for the rare head and neck cancers 2023 Licitra L.Cavalieri S.Baili P.Cavalera E.Mirabile A. + Article (author) -
The SINTART 1 study. A phase II non-randomised controlled trial of induction chemotherapy, surgery, photon-, proton- and carbon ion-based radiotherapy integration in patients with locally advanced resectable sinonasal tumours 2023 Gambazza S.Licitra L. + Article (author) -
The SINTART 2 Study. A phase II non-randomised controlled trial of induction chemotherapy, photon-, proton- and carbon-ion-based radiotherapy integration in patients with locally advanced unresectable sinonasal tumours 2023 Gambazza, S.Licitra, L. + Article (author) -
MRI-based radiomic prognostic signature for locally advanced oral cavity squamous cell carcinoma: development, testing and comparison with genomic prognostic signatures 2023 Cavalieri S.Licitra L. + Article (author) -
Pre-treatment risk factors to predict early cisplatin-related nephrotoxicity in locally advanced head and neck cancer patients treated with chemoradiation: A single Institution experience 2023 Cavalieri S.Platini F.Barretta F.Ottini A.Resteghini C.Licitra L. + Article (author) -
Head and neck cancers survival in Europe, Taiwan, and Japan: results from RARECAREnet Asia based on a privacy-preserving federated infrastructure 2023 Licitra LCavalieri S + Article (author) -
Immune checkpoint inhibitors and Carbon iON radiotherapy In solid Cancers with stable disease (ICONIC) 2023 Cavalieri S.Vitolo V.Molinelli S.Agustoni F.Licitra L. + Article (author) -
Complete Response to Nivolumab in Recurrent/Metastatic HPV-Positive Head and Neck Squamous Cell Carcinoma Patient After Progressive Multifocal Leukoencephalopathy: A Case Report 2022 Perrone F.Delbue S.Cavalieri S.Licitra L. F. + Article (author) -
An Inflammatory Signature to Predict the Clinical Benefit of First-Line Cetuximab Plus Platinum-Based Chemotherapy in Recurrent/Metastatic Head and Neck Cancer 2022 Stefano CavalieriAlessia CaldaraSimona SecondinoPaolo BossiLisa Licitra + Article (author) -
Which future for de-intensified treatments in HPV-related oropharyngeal carcinoma? 2022 Cavalieri SLicitra L + Article (author) -